News About: Pharm. Industry
Abbvie Korea made decisions over personnel affairs
Abbvie Korea(CEO Hong-Ki Yoo), a global biopharmaceutical company, announced regular promotion of Sook-Hyun Kim(44), Head-Immune Business, to an executive director and Director Ui-Hyuk Jung(48), Head-Distribution, to ...
Innovative pharmas’ 2016 business report cards
In 2016, the certified innovative pharmaceutical companies had an increase of sales, but got weaken in operating profit and net profit.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of innovative p...
Total 14 people receiving annual salary more than KRW 500 million in pharma industry
Last year, there were the total 4 people who receive annual salary more than KRW 1 billion in the pharmaceutical industry, such as JW Pharmaceutical Chairman Kyung-Ha Lee and Boryung Pharm Chairman Eun-Sun Kim.
Moreo...
What will be contained in the ‘2nd Promote and Support Plan for Pharmaceutical Industry’?
While the ‘2nd Pharmaceutical Industry Promote and Support Plan’ which will decide the future of the pharmaceutical industry has drawn attention of the pharmaceutical industry, Yakup Shinmoon confirmed an outline of t...
1 of 2 listed pharmas operated with multi-CEO system
1 of the 2 listed pharmaceutical companies were observed to run with the multi-CEO system. Moreover, 3 pharmaceutical companies, such as Samjin Pharm and Kikje Pharma, are operating with the 3-CEO system.
The multi-C...
CJ HealthCare’s goal to make KRW 1 trillion sales, focusing on innovative drug development
CJ HealthCare(CEO Seok-Hee Kang) will put all the company’s capability into developing new synthesized drugs and biomedicines based on its R&D power.
Becoming a 3-year old on 1 April, CJ HealthCare held the 3rd anniv...
Zuellig Pharma to work on enlarging sales with Korean pharmas
Zuellig Pharma Korea has attracted the industry as deciding to actively expand the business with Korean pharmaceutical companies.
Zuellig Pharma Korea President Christophe Piganiol recently announced a plan to expand...
4 pharmas including Hanmi & Green Cross spending more than KRW 100 billion into R&D
Last year, there were 4 listed pharmaceutical companies(Hanmi Pharm, Green Cross, Daewoong Pharmaceutical and Chong Kun Dang) which annually put R&D expenses more than KRW 100 billion.
Including Kwang Dong Pharmaceut...
Hanmi, Beijing Hanmi & Innovent signs co-development partnership of immuno-oncology bispecific antibody
Hanmi Pharm(CEO Sae-Chang Kwon, Jong-Soo Woo) announced on the 30th that it has established a global partnership to jointly develop and commercialize a immune-oncology bispecific antibody with the Chinese biotechnolog...
MSD launches Januvia 25mg, completing portfolio for nephropathy patients
Because launching Januvia 25mg, MSD has become available to make prescriptions for nephropathy patients on every stage.
At the press conference on the 29th, MSD Korea announced the launch of the diabetes type 2 treat...
